CClinicalTrials.gg
Not yet recruitingNCT06090032Updated Oct 19, 2023

Compined SONOPULMONARY Infection Score and APACHE Score in RICU Patients With VAP

An observational study in Respiratory Intensive Care Unit Patients With Ventilator Associated Pneumonia, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-19.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
53
Ages
18 Years and older
Sex
All
01

Study summary

Aim of the study :

  1. Efficacy of Sono pulmonary infection score in combination with APACHE score in early diagnosis of VAP
  2. Assessment of prediction role of combined SIPS SCORE and APACHE SCORE of outcome of VAP patient in RICU
  3. Assessments of role of ultrasonography in early diagnosis and follow up of VAP
Read the detailed description

Pneumonia is a bacterial, viral or fungal infection of the lungs, which causes the alveoli of the lungs to fill up with microorganisms, fluid and inflammatory cells, preventing the lungs from functioning effectively[1]. Ventilator associated pneumonia (VAP) is the most common and a leading cause of death in intensive care unit patient. Ventilator associated pneumonia is caused by prolonged duration of mechanical ventilation ,and prolonged hospital stay, which increase hospital costs, possibly increase mortality rate, and increase antibiotic use in ICU patients , early identification of VAP is an important clinical goal to improve patient outcomes [2]. In recent year several scoring systems have been developed to evaluate the severity of illness and to predict the outcome, especially the mortality rate of intensive care unit patient, such as the Clinical pulmonary infection score (CPIS) or modified (CPIS)The Clinical Pulmonary Infection Score (CPIS) was developed to serves a tool to facilitate the diagnosis of ventilator-associated pneumonia (VAP),The CPIS is calculated on the basis of points assigned for various signs and symptoms of pneumonia (eg, fever and extent of oxygenation mpairment) ,a CPIS has an average between 0-12>6 some studies suggest that CPIS >6 may correlate with VAP Sonar is easy bedside test to diagnose pleural effusion, pneumonia pneumothorax , so recently lung ultrasonography (LUS) incorporated in evaluation and diagnosis of VAP in a new score called sono pulmonary infection score (SPIS) . The (SPIS), where is incorporated LUS finding instead of CXR finding of CPIS is assigned two points for ≥ one area of dynamic air bronchogram. One point was given for ≥ two sub-pleural consolidation or lobar consolidation areas or ≥ one sub-pleural, and ≥one lobar consolidationRecently (combination of SPIS with APACHE score in assessment of VAP is under research ).

02

Conditions studied

  • Respiratory Intensive Care Unit Patients With Ventilator Associated Pneumonia
03

In context

Pneumonia

2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.

This study's planned enrollment of 53 is below the median of 203 across 688 observational studies indexed under Pneumonia.

Browse Pneumonia studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Mechanically ventilated patients after first 48 hours of admission in RICU .

Inclusion criteria

  1. Age >18 yrs
  2. Mechanically ventilated patients after first 48 hours of admission in RICU

Exclusion criteria

Exclusion Criteria:

  1. Age \<18 yrs
  2. Patients already diagnosed pneumonia
  3. Malignancy
  4. patient refused participation in the study.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
53 participants (estimated)
Patient registry
No

Interventions

  • DeviceUltrasound

    We will use ultrasongraphy as a part of assessment in respiratory intensive care unit patients with ventilator associated pneumonia

06

What researchers measure

Primary outcomes

  1. Compined SONOPULMONARY infection score and APACHE score as a predictor of outcome in RICU patients with ventilator associated pneumonia

    Compined SONOPULMONARY infection score and APACHE score as a predictor of outcome of respiratory intensive care unit patients with ventilator associated pneumonia

    Time frame: One year

07

Study locations

No study locations are listed for this record.

08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06090032
Lead sponsor
Assiut University
Responsible party
Lamiaa Hussein Fouda (Doctor, Assiut University) — Principal investigator
First posted
Oct 19, 2023
Start date
Nov 1, 2023 (estimated)
Primary completion
Nov 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
Oct 19, 2023

Study contacts

Lamiaa hussein Fouda, Master
Contact
Lamiaahussein5@gmail.com
01140705774
Sahar farghly youssif
Contact
Saherfr2009@yahoo.com
+201002976708

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion